Risk factor
Resilient to price shocks
Profitability factor
Solid dividends
About
SSY Group Limited, an investment holding company, researches, develops, manufactures, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also...
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EB
Target Price
The average target price of 2005.HK is 4.2 and suggests 45% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell